Clinical Trial Update: Study of Nesiritide in Diastolic Heart Failure. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Nesiritide for diastolic heart failure in Phase 1/2; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Diastolic Heart Failure | Phase 1, Phase 2 | Status: COMPLETED